Walleye Capital’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$330K Sell
14,100
-32,000
-69% -$579K ﹤0.01% 2995
2025
Q4
$654K Buy
46,100
+29,400
+176% +$556K ﹤0.01% 2767
2025
Q3
$413K Buy
16,700
+13,000
+351% +$290K ﹤0.01% 2774
2025
Q2
$84K Buy
+3,700
New +$87.7K ﹤0.01% 3849
2025
Q1
Sell
-300
Closed -$11.9K 4161
2024
Q4
$11.9K Sell
300
-14,600
-98% -$659K ﹤0.01% 4565
2024
Q3
$945K Buy
14,900
+9,600
+181% +$693K ﹤0.01% 2708
2024
Q2
$358K Buy
+5,300
New +$370K ﹤0.01% 3818

Other funds holding ACHC

Walleye Capital's ACHC Position: Q1 2026 in Review

Walleye Capital reduced its Acadia Healthcare (ACHC) stake by 94% in Q1 2026, selling an estimated $30.2M and leaving 109,664 shares worth $2.57M. The position accounts for 0.01% of the portfolio, ranked #1271.

Walleye Capital first reported a position in ACHC in Q3 2019 and has held it in 12 quarters since. The position peaked at $26.7M in Q1 2025. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Walleye Capital held 109,664 shares of Acadia Healthcare worth $2.57M as of Q1 2026.
  • Walleye Capital sold 1,667,407 Acadia Healthcare shares in Q1 2026, an estimated $30.2M.
  • Acadia Healthcare made up 0.01% of Walleye Capital's portfolio in Q1 2026, its #1271 holding.
  • Walleye Capital first reported a position in Acadia Healthcare in Q3 2019 and has held it in 12 quarters since.
  • Walleye Capital's Acadia Healthcare position peaked at $26.7M in Q1 2025.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.